Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAMY M HANNA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1518150283
CMS profile
22700
Location
ORANGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$125,284.74

115 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAMY M HANNA

NPI 1518150283 · CMS profile ID 22700

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

ORANGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1518150283?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAMY M HANNA, NPI 1518150283, CMS profile ID 22700. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1518150283?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RAMY M HANNA, NPI 1518150283, CMS profile ID 22700. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1518150283?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RAMY M HANNA, NPI 1518150283, CMS profile ID 22700, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1518150283?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

115 matching records · $125,284.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 115 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 115.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $680.4909/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086886117 CMS
Novartis Pharmaceuticals Corporation $1,925.0009/19/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086886129 CMS
Aurinia Pharma U.S., Inc. $29.1809/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150681569 CMS
Novartis Pharmaceuticals Corporation $78.4908/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086886109 CMS
Mallinckrodt Hospital Products Inc. $27.3408/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145081064 CMS
Alexion Pharmaceuticals, Inc. $2,010.0008/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094049235 CMS
Aurinia Pharma U.S., Inc. $129.3407/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150681567 CMS
Aurinia Pharma U.S., Inc. $49.6007/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150681565 CMS
Aurinia Pharma U.S., Inc. $28.2006/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150681563 CMS
Alexion Pharmaceuticals, Inc. $19,430.0006/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093892814 CMS
Novartis Pharmaceuticals Corporation $3,300.0006/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086886101 CMS
CALLIDITAS THERAPEUTICS US INC. $950.0006/05/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141516423 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $121.2506/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118040348 CMS
Alexion Pharmaceuticals, Inc. $201.6905/31/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093942949 CMS
Alexion Pharmaceuticals, Inc. $42.0905/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093884929 CMS
Alexion Pharmaceuticals, Inc. $30.0005/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093885409 CMS
Alexion Pharmaceuticals, Inc. $197.9605/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093966068 CMS
Alexion Pharmaceuticals, Inc. $85.8105/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093973826 CMS
Alexion Pharmaceuticals, Inc. $12.0005/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093978986 CMS
Alexion Pharmaceuticals, Inc. $116.2605/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093983823 CMS
Alexion Pharmaceuticals, Inc. $5,360.0005/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094036856 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $46.5005/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118837093 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $29.2905/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118837091 CMS
Alexion Pharmaceuticals, Inc. $61.1805/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093900925 CMS
Alexion Pharmaceuticals, Inc. $3,350.0005/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094026200 CMS
Alexion Pharmaceuticals, Inc. $130.9905/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094043054 CMS
Novartis Pharmaceuticals Corporation $2,200.0005/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086886113 CMS
CALLIDITAS THERAPEUTICS US INC. $98.1105/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141515285 CMS
Alexion Pharmaceuticals, Inc. $3,350.0005/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093909614 CMS
Novartis Pharmaceuticals Corporation $92.5005/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086886099 CMS
Alexion Pharmaceuticals, Inc. $105.9605/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093992483 CMS
Alexion Pharmaceuticals, Inc. $153.8505/03/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094017896 CMS
Alexion Pharmaceuticals, Inc. $33.4905/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094036431 CMS
Alexion Pharmaceuticals, Inc. $38.3904/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093908487 CMS
Alexion Pharmaceuticals, Inc. $33.5304/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093937405 CMS
Alexion Pharmaceuticals, Inc. $63.3804/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093916069 CMS
Alexion Pharmaceuticals, Inc. $1,346.5304/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093949382 CMS
Alexion Pharmaceuticals, Inc. $155.2004/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093985149 CMS
Alexion Pharmaceuticals, Inc. $5,166.2004/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094052374 CMS
AstraZeneca Pharmaceuticals LP $29.7004/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104695454 CMS
Alexion Pharmaceuticals, Inc. $127.5004/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093903560 CMS
Alexion Pharmaceuticals, Inc. $3,350.0004/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094013289 CMS
Alexion Pharmaceuticals, Inc. $670.1404/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094016482 CMS
Alexion Pharmaceuticals, Inc. $28.8504/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093945744 CMS
Alexion Pharmaceuticals, Inc. $4,020.0003/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093906756 CMS
Alexion Pharmaceuticals, Inc. $109.0103/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093981706 CMS
Alexion Pharmaceuticals, Inc. $744.6003/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094011608 CMS
CALLIDITAS THERAPEUTICS US INC. $475.0003/27/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141512405 CMS
Alexion Pharmaceuticals, Inc. $27.5403/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094018576 CMS
Ardelyx, Inc. $19.0003/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146683991 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $23,443.91 31
PY2020 $19,645.05 22
PY2021 $38,328.56 46
PY2022 $85,337.37 101
PY2023 $73,753.78 79
PY2024 $125,284.74 115
PY2025 $80,048.23 65

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $116,845.32 17
PY2024 Principal investigator $109,469.56 9
PY2023 Principal investigator $77,052.79 7
PY2022 Principal investigator $52,740.00 5
PY2021 Principal investigator $120,810.60 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $15.74 11/15/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune Complex Mediated Membranoproliferative Glomerulonephritis (IC-MPGN) No dispute reported 06/30/2026 1190297515
Principal investigator 1 Genentech, Inc. $5,320.00 11/13/2025 Covered Recipient Teaching Hospital
Uci Medical Center
Crovalimab in aHUS adult and adolescent patients No dispute reported 06/30/2026 1211559361
Principal investigator 1 Alexion Pharmaceuticals, Inc. $4,760.00 11/12/2025 Covered Recipient Teaching Hospital
Uci Medical Center
ARTEMIS RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE) A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study No dispute reported 06/30/2026 1185539541
Principal investigator 1 Genentech, Inc. $450.00 10/09/2025 Covered Recipient Teaching Hospital
Uci Medical Center
Crovalimab in aHUS adult and adolescent patients No dispute reported 06/30/2026 1211559358
Principal investigator 1 Novartis Pharmaceuticals Corporation $40.00 10/01/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy No dispute reported 06/30/2026 1190296181
Principal investigator 1 Alexion Pharmaceuticals, Inc. $17,000.00 09/18/2025 Covered Recipient Teaching Hospital
Uci Medical Center
An Observational, Non Interventional, Multi Center, Multi National Study of Patients with Atypical Hemolytic Uremic Syndrome (aHUS Registry) No dispute reported 06/30/2026 1185539543
Principal investigator 1 Calliditas Therapeutics US Inc. $31,460.00 09/08/2025 Non-covered Recipient Entity
REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE
Nef-403 No dispute reported 06/30/2026 1235023476
Principal investigator 1 Alexion Pharmaceuticals, Inc. $1,320.00 08/06/2025 Covered Recipient Teaching Hospital
Uci Medical Center
a phase 3,randomized,double blind,placebo controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with immunoglobulin a nephropathy IgAN No dispute reported 06/30/2026 1185539539
Principal investigator 1 SANOFI US SERVICES INC. $7,194.00 06/16/2025 Covered Recipient Teaching Hospital
Uci Medical Center
ACT - POC clinical study - CD40L mAb - frexalimab No dispute reported 06/30/2026 1226143175
Principal investigator 1 Calliditas Therapeutics US Inc. $792.00 06/04/2025 Non-covered Recipient Entity
REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE
Nef-403 No dispute reported 06/30/2026 1235023438
Principal investigator 1 Genentech, Inc. $150.00 04/29/2025 Covered Recipient Teaching Hospital
Uci Medical Center
Crovalimab in aHUS adult and adolescent patients No dispute reported 06/30/2026 1211559354
Principal investigator 1 Genentech, Inc. $1,227.00 04/22/2025 Covered Recipient Teaching Hospital
Uci Medical Center
Crovalimab in aHUS adult and adolescent patients No dispute reported 06/30/2026 1211559350
Principal investigator 1 GENZYME CORPORATION $35,401.00 04/07/2025 Covered Recipient Teaching Hospital
Uci Medical Center
ACT - POC clinical study - CD40L mAb - frexalimab No dispute reported 06/30/2026 1226143153
Principal investigator 1 Novartis Pharmaceuticals Corporation $5,188.00 04/01/2025 Non-covered Recipient Entity
REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE ACCOUNTING OFFICE
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune Complex Mediated Membranoproliferative Glomerulonephritis (IC-MPGN) No dispute reported 06/30/2026 1190300137
Principal investigator 1 Novartis Pharmaceuticals Corporation $5,640.36 02/04/2025 Non-covered Recipient Entity
REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE ACCOUNTING OFFICE
A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy No dispute reported 06/30/2026 1190300141
Principal investigator 1 Novartis Pharmaceuticals Corporation $473.35 01/15/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune Complex Mediated Membranoproliferative Glomerulonephritis (IC-MPGN) No dispute reported 06/30/2026 1190295628
Principal investigator 1 Novartis Pharmaceuticals Corporation $413.87 01/01/2025 Covered Recipient Teaching Hospital
Uci Medical Center
A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy No dispute reported 06/30/2026 1190295636